The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of prior endocrine therapy on radiographic progression-free survival (rPFS) in patients (pts) with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302.
Stephane Oudard
Consultant or Advisory Role - Bayer; Novartis; Pfizer; Sanofi ; Takeda
Honoraria - Bayer; Janssen; Novartis; Pfizer; Sanofi ; Takeda
Thian San Kheoh
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Margaret K. Yu
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Janssen Research & Development
Matthew R. Smith
Consultant or Advisory Role - Janssen
Research Funding - Janssen
Eric Jay Small
No relevant relationships to disclose
Peter F.A. Mulders
No relevant relationships to disclose
Karim Fizazi
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Dana E. Rathkopf
Research Funding - Johnson & Johnson
Fred Saad
Consultant or Advisory Role - Astellas Pharma; Janssen
Honoraria - Astellas Pharma; Janssen
Research Funding - Astellas Pharma; Janssen
Howard I. Scher
Consultant or Advisory Role - Aragon Pharmaceuticals (U); Bristol-Myers Squibb (U); Celgene (U); Enzon; Johnson & Johnson (U); Medivation (U); Millennium; Novartis; ODEON; Ortho Biotech; Veridex (U)
Research Funding - Aragon Pharmaceuticals; Exelixis; Janssen; Medivation; Veridex
Joaquim Bellmunt
Consultant or Advisory Role - Janssen
Mary-Ellen Taplin
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Research Funding - Janssen
Ian D. Davis
Consultant or Advisory Role - Astellas Pharma (U); Bayer (U); Bristol-Myers Squibb (U); GlaxoSmithKline (U); Janssen (U); Medivation (U); Novartis (U); Pfizer (U); Sanofi (U)
Dirk L. Schrijvers
Consultant or Advisory Role - Janssen Pharmaceutical
Honoraria - Janssen Pharmaceutical
Research Funding - Janssen Pharmaceutical
Andrew Protheroe
No relevant relationships to disclose
Arturo Molina
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Thomas W. Griffin
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Johann Sebastian De Bono
Employment or Leadership Position - The Institute of Cancer Research
Consultant or Advisory Role - Astellas Pharma; Johnson & Johnson; Medivation
Honoraria - Astellas Pharma; Johnson & Johnson; Medivation
Charles J. Ryan
Honoraria - Janssen